Variant report

Variant	nsv508184
Chromosome Location	chr2:179896384-179965419
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr2:179896233-179897238	GM12878	blood:	n/a	n/a
2	ATF2	chr2:179896288-179897163	GM12878	blood:	n/a	n/a
3	BATF	chr2:179896385-179897191	GM12878	blood:	n/a	chr2:179896815-179896825 chr2:179896814-179896825
4	BATF	chr2:179902540-179902916	GM12878	blood:	n/a	n/a
5	BATF	chr2:179962975-179963390	GM12878	blood:	n/a	n/a
6	BCL11A	chr2:179896398-179897128	GM12878	blood:	n/a	n/a
7	BCL11A	chr2:179896464-179896913	GM12878	blood:	n/a	n/a
8	BCL3	chr2:179896426-179897244	GM12878	blood:	n/a	n/a
9	BCLAF1	chr2:179896411-179897213	GM12878	blood:	n/a	n/a
10	BCLAF1	chr2:179960686-179961274	GM12878	blood:	n/a	n/a
11	BCLAF1	chr2:179896181-179897435	GM12878	blood:	n/a	n/a
12	BHLHE40	chr2:179960763-179961083	GM12878	blood:	n/a	n/a
13	BHLHE40	chr2:179909469-179909595	GM12878	blood:	n/a	n/a
14	BHLHE40	chr2:179896442-179896875	GM12878	blood:	n/a	n/a
15	BHLHE40	chr2:179902783-179902887	GM12878	blood:	n/a	n/a
16	BHLHE40	chr2:179962980-179963298	GM12878	blood:	n/a	n/a
17	BHLHE40	chr2:179909245-179909255	GM12878	blood:	n/a	n/a
18	BHLHE40	chr2:179897415-179897506	GM12878	blood:	n/a	n/a
19	BRCA1	chr2:179914597-179914797	GM12878	blood:	n/a	n/a
20	CEBPB	chr2:179923239-179923633	ECC-1	luminal epithelium:	n/a	n/a
21	CEBPB	chr2:179933074-179933386	IMR90	lung:	n/a	chr2:179933201-179933212 chr2:179933199-179933212 chr2:179933201-179933210 chr2:179933201-179933210 chr2:179933201-179933210 chr2:179933199-179933210 chr2:179933199-179933212 chr2:179933201-179933210
22	CEBPB	chr2:179923256-179923555	A549	lung:	n/a	n/a
23	CEBPB	chr2:179936669-179936850	HepG2	liver:	n/a	n/a
24	CEBPB	chr2:179923270-179923638	Hela-S3	cervix:	n/a	n/a
25	CEBPB	chr2:179933099-179933373	A549	lung:	n/a	chr2:179933201-179933212 chr2:179933199-179933212 chr2:179933201-179933210 chr2:179933201-179933210 chr2:179933201-179933210 chr2:179933199-179933210 chr2:179933199-179933212 chr2:179933201-179933210
26	CEBPB	chr2:179923259-179923640	ECC-1	luminal epithelium:	n/a	n/a
27	CEBPB	chr2:179933047-179933357	HepG2	liver:	n/a	chr2:179933201-179933212 chr2:179933199-179933212 chr2:179933201-179933210 chr2:179933201-179933210 chr2:179933201-179933210 chr2:179933199-179933210 chr2:179933199-179933212 chr2:179933201-179933210
28	CEBPB	chr2:179923257-179923619	H1-hESC	embryonic stem cell:	n/a	n/a
29	CEBPB	chr2:179923299-179923594	HepG2	liver:	n/a	n/a
30	CEBPB	chr2:179903067-179903239	IMR90	lung:	n/a	n/a
31	CEBPB	chr2:179916157-179916328	HepG2	liver:	n/a	n/a
32	CHD1	chr2:179913186-179913556	GM12878	blood:	n/a	n/a
33	CHD1	chr2:179897398-179897468	GM12878	blood:	n/a	n/a
34	CHD2	chr2:179960711-179961063	GM12878	blood:	n/a	n/a
35	CHD2	chr2:179923266-179923423	H1-hESC	embryonic stem cell:	n/a	n/a
36	CHD2	chr2:179909327-179909557	GM12878	blood:	n/a	n/a
37	CHD2	chr2:179896431-179897361	GM12878	blood:	n/a	n/a
38	CREB1	chr2:179896235-179897356	GM12878	blood:	n/a	n/a
39	CTCF	chr2:179960740-179960890	GM12864	blood:	n/a	n/a
40	CTCF	chr2:179931280-179931430	HepG2	liver:	n/a	n/a
41	CTCF	chr2:179960760-179960910	GM12871	blood:	n/a	n/a
42	CTCF	chr2:179914600-179914750	GM12873	blood:	n/a	n/a
43	CTCF	chr2:179960980-179961130	GM12865	blood:	n/a	n/a
44	CTCF	chr2:179940600-179940750	GM12873	blood:	n/a	n/a
45	CTCF	chr2:179961000-179961150	GM12872	blood:	n/a	n/a
46	CTCF	chr2:179941419-179941452	GM10266	blood:	n/a	n/a
47	CTCF	chr2:179961132-179961174	GM19239	blood:	n/a	n/a
48	CTCF	chr2:179960811-179960831	GM19238	blood:	n/a	n/a
49	CTCF	chr2:179960800-179960950	GM12872	blood:	n/a	n/a
50	CTCF	chr2:179961040-179961190	GM12873	blood:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:179916184-179916234	NHDF-neo	bronchial:	n/a
2	chr2:179916184-179916234	NHDF-neo	bronchial:	n/a
3	chr2:179897289-179897339	HRE	kidney:	n/a
4	chr2:179914868-179914918	HCPEpiC	choroid plexus:	n/a
5	chr2:179914864-179914914	GM12878	blood:	n/a
6	chr2:179914864-179914914	HL-60	blood:	n/a
7	chr2:179897289-179897339	SAEC	small airway:	n/a
8	chr2:179897289-179897339	Jurkat	blood:	n/a
9	chr2:179916184-179916234	HepG2	liver:	n/a
10	chr2:179914864-179914914	T-47D	breast:	n/a
11	chr2:179923444-179923494	MCF-7	breast:	n/a
12	chr2:179897289-179897339	PrEC	prostate:	n/a
13	chr2:179916184-179916234	AoSMC	blood vessel:	n/a
14	chr2:179916184-179916234	SK-N-SH	brain:	n/a
15	chr2:179914868-179914918	ovcar-3	ovarian:	n/a
16	chr2:179923444-179923494	HEK293	kidney:	embryo
17	chr2:179897289-179897339	HCT-116	colon:	n/a
18	chr2:179914868-179914918	HCT-116	colon:	n/a
19	chr2:179914864-179914914	NHBE	bronchial:	n/a
20	chr2:179914868-179914918	SK-N-SH_RA	brain:	n/a
21	chr2:179914864-179914914	K562	blood:	n/a
22	chr2:179923444-179923494	AG04450	lung:	fetal
23	chr2:179914864-179914914	PFSK-1	brain:	n/a
24	chr2:179914864-179914914	CMK	blood:	n/a
25	chr2:179914864-179914914	HAEpiC	amniotic membrane:	n/a
26	chr2:179897289-179897339	ovcar-3	ovarian:	n/a
27	chr2:179923444-179923494	RPTEC	kidney:	n/a
28	chr2:179914864-179914914	HCPEpiC	choroid plexus:	n/a
29	chr2:179914864-179914914	A549	lung:	n/a
30	chr2:179923444-179923494	HCT-116	colon:	n/a
31	chr2:179923444-179923494	NHDF-neo	bronchial:	n/a
32	chr2:179923444-179923494	HNPCEpiC	eye:	n/a
33	chr2:179923444-179923494	AoSMC	blood vessel:	n/a
34	chr2:179914868-179914918	Hepatocyte	liver:	n/a
35	chr2:179916184-179916234	AG04449	skin:	fetal
36	chr2:179923444-179923494	HL-60	blood:	n/a
37	chr2:179914864-179914914	U87	brain:	n/a
38	chr2:179916184-179916234	HCF	heart:	n/a
39	chr2:179916184-179916234	CMK	blood:	n/a
40	chr2:179916184-179916234	ovcar-3	ovarian:	n/a
41	chr2:179914868-179914918	ECC-1	luminal epithelium:	n/a
42	chr2:179923444-179923494	ECC-1	luminal epithelium:	n/a
43	chr2:179916184-179916234	Hepatocyte	liver:	n/a
44	chr2:179914864-179914914	PrEC	prostate:	n/a
45	chr2:179914868-179914918	HMEC	breast:	n/a
46	chr2:179914868-179914918	PFSK-1	brain:	n/a
47	chr2:179916184-179916234	HRE	kidney:	n/a
48	chr2:179914864-179914914	ECC-1	luminal epithelium:	n/a
49	chr2:179916184-179916234	NT2-D1	testis:	n/a
50	chr2:179897289-179897339	BJ	skin:	n/a

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr2:179962282..179964737-chr2:179968470..179970797,2	MCF-7	breast:

Variant related genes	Relation type
CCDC141	TF binding region
CCDC141	CpG island

Extended variants
information (count: 2739 )
Associated
traits (count: 55 )

Variant overlapped rSNPs/rCNVs (count:2739 , 50 per page) page: 1 2 3 4 5 6 7 ... 55

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs558861689	chr2:179896397-179896398	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs575602000	chr2:179896405-179896406	Enhancers Weak transcription Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs4435492	chr2:179896416-179896417	Enhancers Weak transcription Strong transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs533561517	chr2:179896423-179896424	Enhancers Weak transcription Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs574658668	chr2:179896470-179896471	Enhancers Weak transcription Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs143252549	chr2:179896509-179896510	Enhancers Weak transcription Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs1875782	chr2:179896526-179896527	Enhancers Weak transcription Strong transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs190618275	chr2:179896537-179896538	Enhancers Weak transcription Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs577196789	chr2:179896557-179896558	Enhancers Weak transcription Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs545874211	chr2:179896559-179896560	Enhancers Weak transcription Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs182815348	chr2:179896566-179896567	Enhancers Weak transcription Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs529421914	chr2:179896594-179896595	Enhancers Weak transcription Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs531890405	chr2:179896603-179896604	Flanking Active TSS Weak transcription Enhancers Strong transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs548425560	chr2:179896633-179896634	Flanking Active TSS Weak transcription Enhancers Strong transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs561965387	chr2:179896634-179896635	Flanking Active TSS Weak transcription Enhancers Strong transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs185622126	chr2:179896640-179896641	Flanking Active TSS Weak transcription Enhancers Strong transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs546704740	chr2:179896682-179896683	Flanking Active TSS Weak transcription Enhancers Strong transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs566444137	chr2:179896713-179896714	Flanking Active TSS Weak transcription Enhancers Strong transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs2007326	chr2:179896787-179896788	Flanking Active TSS Weak transcription Enhancers Strong transcription Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
20	rs551895280	chr2:179896811-179896812	Flanking Active TSS Enhancers Weak transcription Strong transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs191122462	chr2:179896886-179896887	Flanking Active TSS Enhancers Weak transcription Strong transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs547031964	chr2:179897013-179897014	Enhancers Strong transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs569239779	chr2:179897066-179897067	Enhancers Strong transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs114634294	chr2:179897070-179897071	Enhancers Strong transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs146195312	chr2:179897094-179897095	Enhancers Strong transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs568294371	chr2:179897115-179897116	Enhancers Strong transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs533724880	chr2:179897123-179897124	Enhancers Strong transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs554288764	chr2:179897188-179897189	Enhancers Strong transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs77363493	chr2:179897221-179897222	Enhancers Strong transcription Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs546236372	chr2:179897249-179897250	Enhancers Strong transcription Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs78955170	chr2:179897254-179897255	Enhancers Strong transcription Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs575998207	chr2:179897289-179897290	Enhancers Strong transcription Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs139092579	chr2:179897290-179897291	Enhancers Strong transcription Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs552518658	chr2:179897314-179897315	Enhancers Strong transcription Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs562024845	chr2:179897327-179897328	Enhancers Strong transcription Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs569404388	chr2:179897353-179897354	Enhancers Strong transcription Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs527929519	chr2:179897368-179897369	Enhancers Strong transcription Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs143957674	chr2:179897388-179897389	Enhancers Strong transcription Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs2007575	chr2:179897458-179897459	Enhancers Strong transcription Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs532111050	chr2:179897465-179897466	Enhancers Strong transcription Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs538058492	chr2:179897514-179897515	Enhancers Strong transcription Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs148107949	chr2:179897521-179897522	Enhancers Strong transcription Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs375428072	chr2:179897523-179897524	Enhancers Strong transcription Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs568887215	chr2:179897558-179897559	Enhancers Strong transcription Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs531316627	chr2:179897591-179897592	Enhancers Strong transcription Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs79124739	chr2:179897611-179897612	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs376190092	chr2:179897626-179897627	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs113984386	chr2:179897656-179897657	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs568045916	chr2:179897715-179897716	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs546345181	chr2:179897722-179897723	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:55)

Disease	PMID	Source
Breast cancer	17603634	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Ependymoma	16718352	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	18522746	CNVD
Neurodevelopmental disorder	22521361	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Seminomas	18059402	CNVD
Testicular germ cell tumor	18059402	CNVD
Breast cancer	16272173	CNVD
Ewing''s sarcoma	17952124	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
Colorectal cancer	16272173	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Lung cancer	18438408	CNVD
Glioblastoma	21080181	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Prostate cancer	18632612	CNVD
Sudden cardiac death	19188705	CNVD
Acute myeloid leukemia	20729466	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
small cell lung cancer	20016488	CNVD
Myelofibrosis	22110671	CNVD
Schizophrenia	18923514	CNVD
Schizophrenia	22241247	CNVD
Mental retardation	21062444	CNVD
Facial dysmorphism	20548289	CNVD
Mental retardation	20548289	CNVD
Schizophrenia	19348701	CNVD
Muscular dystrophy	17160897	CNVD
Cardiomyopathy	17576883	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:790 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:179887800-179896800	Weak transcription	Right Ventricle	heart
2	chr2:179893000-179896400	Weak transcription	Primary hematopoietic stem cells	blood
3	chr2:179893000-179896800	Weak transcription	Right Atrium	heart
4	chr2:179893000-179897000	Weak transcription	H9 Cell Line	embryonic stem cell
5	chr2:179893200-179896400	Weak transcription	ES-I3 Cell Line	embryonic stem cell
6	chr2:179893200-179896800	Weak transcription	H1 Cell Line	embryonic stem cell
7	chr2:179894200-179896400	Enhancers	Primary T cells from cord blood	blood
8	chr2:179894200-179897000	Enhancers	Fetal Heart	heart
9	chr2:179894400-179896400	Enhancers	Primary T regulatory cells fromperipheralblood	blood
10	chr2:179894800-179906800	Strong transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
11	chr2:179895000-179896400	Enhancers	Dnd41	blood
12	chr2:179895000-179897000	Weak transcription	Pancreatic Islets	Pancreatic Islet
13	chr2:179895200-179896600	Enhancers	Primary T helper cells fromperipheralblood	blood
14	chr2:179895200-179897600	Enhancers	Primary hematopoietic stem cells short term culture	blood
15	chr2:179895400-179896400	Enhancers	Primary T helper naive cells from peripheral blood	blood
16	chr2:179895400-179896600	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
17	chr2:179895400-179896800	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
18	chr2:179895600-179896400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
19	chr2:179895600-179896600	Enhancers	Primary T helper naive cells fromperipheralblood	blood
20	chr2:179895600-179896800	Enhancers	Primary T killer memory cells from peripheral blood	blood
21	chr2:179895600-179897600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
22	chr2:179896000-179896400	Enhancers	Primary B cells from cord blood	blood
23	chr2:179896000-179896600	Flanking Active TSS	GM12878-XiMat	blood
24	chr2:179896000-179896600	Enhancers	HSMMtube	muscle
25	chr2:179896000-179896800	Enhancers	Primary B cells from peripheral blood	blood
26	chr2:179896000-179896800	Enhancers	Primary T killer naive cells fromperipheralblood	blood
27	chr2:179896000-179897200	Enhancers	Muscle Satellite Cultured Cells	--
28	chr2:179896000-179897600	Flanking Active TSS	Primary T helper cells PMA-I stimulated	--
29	chr2:179896200-179896600	Weak transcription	iPS-20b Cell Line	embryonic stem cell
30	chr2:179896200-179896600	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
31	chr2:179896200-179896800	Weak transcription	Left Ventricle	heart
32	chr2:179896200-179897200	Enhancers	Skeletal Muscle Male	skeletal muscle
33	chr2:179896200-179897400	Enhancers	HUES48 Cell Line	embryonic stem cell
34	chr2:179896400-179896600	Enhancers	ES-I3 Cell Line	embryonic stem cell
35	chr2:179896400-179896600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
36	chr2:179896400-179896600	Flanking Active TSS	Primary hematopoietic stem cells	blood
37	chr2:179896400-179897000	Enhancers	Skeletal Muscle Female	skeletal muscle
38	chr2:179896400-179897200	Flanking Active TSS	Primary B cells from cord blood	blood
39	chr2:179896400-179897200	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
40	chr2:179896400-179897200	Enhancers	HSMM	muscle
41	chr2:179896400-179897400	Enhancers	Fetal Thymus	thymus
42	chr2:179896400-179897400	Flanking Active TSS	Dnd41	blood
43	chr2:179896400-179897600	Enhancers	iPS-15b Cell Line	embryonic stem cell
44	chr2:179896400-179897600	Enhancers	iPS-18 Cell Line	embryonic stem cell
45	chr2:179896400-179897600	Flanking Active TSS	Primary T cells from cord blood	blood
46	chr2:179896400-179897600	Flanking Active TSS	Primary T helper naive cells from peripheral blood	blood
47	chr2:179896400-179897600	Flanking Active TSS	Primary T regulatory cells fromperipheralblood	blood
48	chr2:179896600-179896800	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
49	chr2:179896600-179896800	Active TSS	Primary T cells fromperipheralblood	blood
50	chr2:179896600-179896800	Enhancers	Primary hematopoietic stem cells	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links